These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10190742)

  • 1. Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients.
    Locarnini S; Birch C
    J Hepatol; 1999 Mar; 30(3):536-50. PubMed ID: 10190742
    [No Abstract]   [Full Text] [Related]  

  • 2. Entecavir surprise.
    Hirsch MS
    N Engl J Med; 2007 Jun; 356(25):2641-3. PubMed ID: 17582076
    [No Abstract]   [Full Text] [Related]  

  • 3. Entecavir can select for M184V of HIV-1: a case of an HIV/hepatitis B (HBV) naïve patient treated for chronic HBV.
    Jain MK; Zoellner CL
    AIDS; 2007 Nov; 21(17):2365-6. PubMed ID: 18090296
    [No Abstract]   [Full Text] [Related]  

  • 4. Lamivudine for chronic hepatitis B and HIV co-infection.
    Carton JA; Maradona JA; Asensi V; Rodríguez M; Martínez A
    AIDS; 1999 May; 13(8):1002-3. PubMed ID: 10371189
    [No Abstract]   [Full Text] [Related]  

  • 5. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.
    Coffin CS; Osiowy C; Myers RP; Gill MJ
    J Clin Virol; 2013 Jun; 57(2):103-8. PubMed ID: 23465393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
    Benhamou Y; Dohin E; Lunel-Fabiani F; Poynard T; Huraux JM; Katlama C; Opolon P; Gentilini M
    Lancet; 1995 Feb; 345(8946):396-7. PubMed ID: 7845151
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].
    Wang FS; Zhang JY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):164-6. PubMed ID: 19554778
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.
    Zoulim F
    Antiviral Res; 2004 Oct; 64(1):1-15. PubMed ID: 15451174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of chronic hepatitis B: new goals and new treatments.
    Mauss S
    Minerva Med; 2009 Dec; 100(6):447-58. PubMed ID: 20010480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is hepatitis virus resistance to antiviral drugs a threat?
    Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1369-72. PubMed ID: 22537445
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
    Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
    AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic agents for chronic hepatitis B.
    Brahmania M; Feld J; Arif A; Janssen HL
    Lancet Infect Dis; 2016 Feb; 16(2):e10-21. PubMed ID: 26795693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Entecavir therapy against hepatitis B].
    Kato N; Omata M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():340-4. PubMed ID: 15453342
    [No Abstract]   [Full Text] [Related]  

  • 16. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
    Locarnini S; Warner N
    Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absent inhibition of hepatitis B virus replication by azidothymidine in patients chronically coinfected by HIV-1 and HBV.
    Gallian P; De Lamballerie X; Lehucher MP; Dhiver C; Ravaux I
    New Microbiol; 1996 Apr; 19(2):167-9. PubMed ID: 8722313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy for chronic hepatitis B: the earlier, the better?
    Hu J; Nguyen D
    Trends Microbiol; 2004 Oct; 12(10):431-3. PubMed ID: 15381188
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay.
    Herz AV; Bonhoeffer S; Anderson RM; May RM; Nowak MA
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7247-51. PubMed ID: 8692977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment in every detected virus replication. New guideline for therapy of hepatitis B publicized].
    MMW Fortschr Med; 2007 Jul; 149(29-30):61. PubMed ID: 17703695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.